T1	Participants 93 102	in Asians
T2	Participants 270 285	in Asian people
T3	Participants 453 513	Patients of resectable esophageal cancer of comparable stage
T4	Participants 1125 1275	Up to December 2006, eighty-seven patients of stage II and III, including 71 patients of middle third lesions and 16 lower third lesions were enrolled
